{10 (avatrombopag 20 MG Oral Tablet) } Pack — RxCUI 2045952
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Avatrombopag: what it is, how it’s used, side effects, and interactions.
- Your platelet count is too low, which means your blood can't clot properly and you're at higher risk for serious bleeding. Avatrombopag works by telling your bone marrow to make mo...
- What exactly is this medicine doing for me — why do I need it?
- Yes, every dose — whether it's the tablet or the Doptelet Sprinkle granules — needs to be taken with food. Food helps the medicine absorb properly. If you're using Doptelet Sprinkl...
- Do I have to take it with food every time?
🕸️ Concept Web — How {10 (avatrombopag 20 MG Oral Tablet) } Pack Connects
RxCUI 2045952 Generic pack · GPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Avatrombopag
2045726IN
-
Avatrombopag
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Doptelet
2045953BN
-
Doptelet
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Avatrombopag Oral Tablet
2045950SCDF -
Avatrombopag Oral Product
2045948SCDG -
Avatrombopag Pill
2045949SCDG -
Avatrombopag Oral Tablet [Doptelet]
2045955SBDF -
Doptelet Oral Product
2045956SBDG -
Doptelet Pill
2045957SBDG -
Pack
746839DF -
Oral Product
1151131DFG - +1 more in this family
-
Avatrombopag Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Avatrombopag 20 MG Oral Tablet
2045951SCD -
Avatrombopag 20 MG
2045947SCDC -
Avatrombopag 20 MG Oral Tablet [Doptelet]
2045958SBD -
Avatrombopag 20 MG [Doptelet]
2045954SBDC
-
Avatrombopag 20 MG Oral Tablet
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
🔀 Generic ⇄ Brand Crosswalk
Generic (Clinical) Concepts
-
Avatrombopag 20 MG Oral Tablet
SCD · 2045951 -
Avatrombopag 20 MG
SCDC · 2045947 -
Avatrombopag Oral Tablet
SCDF · 2045950 -
Avatrombopag Oral Product
SCDG · 2045948 -
Avatrombopag Pill
SCDG · 2045949
Brand-Name Concepts
-
Avatrombopag 20 MG Oral Tablet [Doptelet]
SBD · 2045958 -
{10 (avatrombopag 20 MG Oral Tablet [Doptelet]) } Pack [Doptelet 40 MG Daily Dose Carton]
BPCK · 2045959 -
Avatrombopag 20 MG [Doptelet]
SBDC · 2045954 -
Avatrombopag Oral Tablet [Doptelet]
SBDF · 2045955 -
Doptelet Oral Product
SBDG · 2045956 -
Doptelet Pill
SBDG · 2045957 -
Doptelet
BN · 2045953
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71369-0010-30 | 1 BOTTLE in 1 CARTON (71369-010-30) / 30 GRANULE in 1 BOTTL... | Doptelet Sprinkle | AkaRx, Inc. | 2025-07-25 |
| 71369-0020-10 | 1 BLISTER PACK in 1 CARTON (71369-020-10) / 10 TABLET, FILM... | DOPTELET | AkaRx, Inc. | 2018-05-23 |
| 71369-0020-15 | 1 BLISTER PACK in 1 CARTON (71369-020-15) / 15 TABLET, FILM... | DOPTELET | AkaRx, Inc. | 2018-05-23 |
| 71369-0020-30 | 2 BLISTER PACK in 1 CARTON (71369-020-30) / 15 TABLET, FILM... | DOPTELET | AkaRx, Inc. | 2019-06-26 |
🗃️ Sources & Limits
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.